Engineered Mesenchymal Stem Cell‐Derived Extracellular Vesicles Scavenge Self‐Antigens for Psoriasis Therapy via Modulating Metabolic and Immunological Disorders (Adv. Sci. 6/2025)

Xin Zhou; Bo Tang; Qing Huang; Siyu Yang; Yang Jiang; Lizhou Xu; Wen Chen; Guangchang Shan; Xuankai Liao; Chongchao Hou; Zhihong Yao; Chaowei Zou; Rongying Ou; Yunsheng Xu; Danyang Li

doi:10.1002/advs.202570031

journal article·2025-02Open access

Engineered Mesenchymal Stem Cell‐Derived Extracellular Vesicles Scavenge Self‐Antigens for Psoriasis Therapy via Modulating Metabolic and Immunological Disorders (Adv. Sci. 6/2025)

Xin Zhou, Bo Tang, Qing Huang, Siyu Yang, Yang Jiang, Lizhou Xu, Wen Chen, Guangchang Shan, Xuankai Liao, Chongchao Hou, Zhihong Yao, Chaowei Zou, Rongying Ou, Yunsheng Xu, Danyang Li

Advanced Science· Volume 12· Issue 6

Publisher page Open full text

Source abstract

Abstract

Novel Therapy for Psoriasis In article number 2410067, Xin Zhou, Yunsheng Xu, Danyang Li, and co-workers present a novel engineered mesenchymal stem cell-derived extracellular vesicles for treating psoriasis, a condition currently lacks a complete cure. This approach can effectively reduce psoriasis-specific self-antigens and modulate both metabolic and immunological disorders, thereby providing new insights for psoriasis therapy.

Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References

Reference metadata was not supplied for this record.